Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Jenne

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 2, 2004
Aptamers in research and drug developmentGünter Mayer, Andreas Jenne
Current Opinion in Drug Discovery & Development|March 13, 2003
Aptamers and aptazymes: accelerating small molecule drug discoveryPetra Burgstaller, Andreas Jenne, Michael Blind
Angewandte Chemie (International Ed. in English)|October 10, 2001
An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for supportNicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Real-Time Characterization of Ribozymes by Fluorecence Resonance Energy Transfer (FRET)Andreas Jenne, Walter Gmelin, Nikolai Raffler, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
An Allosteric Ribozyme Regulated by DoxycylineNicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 2, 2004
Aptamers in research and drug developmentGünter Mayer, Andreas Jenne
Current Opinion in Drug Discovery & Development|March 13, 2003
Aptamers and aptazymes: accelerating small molecule drug discoveryPetra Burgstaller, Andreas Jenne, Michael Blind
Angewandte Chemie (International Ed. in English)|October 10, 2001
An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for supportNicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Real-Time Characterization of Ribozymes by Fluorecence Resonance Energy Transfer (FRET)Andreas Jenne, Walter Gmelin, Nikolai Raffler, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
An Allosteric Ribozyme Regulated by DoxycylineNicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Pageof 1